References
- Nussenblatt RB. The natural history of uveitis. Int Ophthalmol. 1990;14:303–308. doi:https://doi.org/10.1007/BF00163549.
- Acharya NR, Tham VM, Esterberg E, et al. Incidence and prevalence of uveitis: results from the pacific ocular inflammation study. JAMA Ophthalmol. 2013;131:1405–1412. doi:https://doi.org/10.1001/jamaophthalmol.2013.4237.
- Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California; the Northern California epidemiology of uveitis study. Ophthalmology. 2004;111:491–500. doi:https://doi.org/10.1016/j.ophtha.2003.06.014. discussion.
- Suhler EB, Lloyd MJ, Choi D, et al. Incidence and prevalence of uveitis in veterans affairs medical centers of the Pacific Northwest. Am J Ophthalmol. 2008;146(890–6):e8. doi:https://doi.org/10.1016/j.ajo.2008.09.014.
- Llorenc V, Mesquida M, Sainz de la Maza M, et al. Epidemiology of uveitis in a Western urban multiethnic population. The challenge of globalization. Acta Ophthalmol. 2015;93:561–567. doi:https://doi.org/10.1111/aos.2015.93.issue-6.
- Hwang DK, Chou YJ, Pu CY, Chou P. Epidemiology of uveitis among the Chinese population in Taiwan: a population-based study. Ophthalmology. 2012;119:2371–2376. doi:https://doi.org/10.1016/j.ophtha.2012.05.026.
- Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature Working G. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509–516.
- Bajwa A, Osmanzada D, Osmanzada S, et al. Epidemiology of uveitis in the mid-Atlantic United States. Clin Ophthalmol. 2015;9:889–901. doi:https://doi.org/10.2147/OPTH.
- Venkatesh P, Gogia V, Shah B, et al. Patterns of uveitis at the Apex Institute for Eye Care in India: results from a prospectively enrolled patient data base (2011–2013). Int Ophthalmol. 2016;36:365–372. doi:https://doi.org/10.1007/s10792-015-0128-9.
- McCannel CA, Holland GN, Helm CJ, et al. Causes of uveitis in the general practice of ophthalmology. UCLA community-based uveitis study group. Am J Ophthalmol. 1996;121:35–46. doi:https://doi.org/10.1016/S0002-9394(14)70532-X.
- Dogra M, Singh R, Agarwal A, et al. Epidemiology of uveitis in a tertiary-care referral institute in North India. Ocul Immunol Inflamm. 2017;25:S46–S53. doi: https://doi.org/10.1080/09273948.2016.1255761
- Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol. 2007;55:173–183. doi:https://doi.org/10.4103/0301-4738.31936.
- Lardenoye CW, van Kooij B, Rothova A. Impact of macular edema on visual acuity in uveitis. Ophthalmology. 2006;113:1446–1449. doi:https://doi.org/10.1016/j.ophtha.2006.03.027.
- Durrani OM, Tehrani NN, Marr JE, et al. Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol. 2004;88:1159–1162. doi:https://doi.org/10.1136/bjo.2003.037226.
- Dick AD, Tundia N, Sorg R, et al. Risk of ocular complications in patients with noninfectious intermediate uveitis, posterior uveitis, or panuveitis. Ophthalmology. 2016;123:655–662. doi:https://doi.org/10.1016/j.ophtha.2015.10.028.
- Markomichelakis NN, Halkiadakis I, Pantelia E, et al. Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography. Ophthalmology. 2004;111:946–953. doi:https://doi.org/10.1016/j.ophtha.2003.08.037.
- Tomkins-Netzer O, Talat L, Bar A, et al. Long-term clinical outcome and causes of vision loss in patients with uveitis. Ophthalmology. 2014;121:2387–2392. doi:https://doi.org/10.1016/j.ophtha.2014.07.007.
- Multicenter Uveitis Steroid Treatment Trial Research G, Kempen JH, Altaweel MM. The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. Am J Ophthalmol. 2010;149(550–61):e10.
- Nicholson BP, Zhou M, Rostamizadeh M, et al. Epidemiology of epiretinal membrane in a large cohort of patients with uveitis. Ophthalmology. 2014;121:2393–2398. doi:https://doi.org/10.1016/j.ophtha.2014.06.015.
- Sheybani A, Harocopos GJ, Rao PK. Immunohistochemical study of epiretinal membranes in patients with uveitis. J Ophthalmic Inflamm Infect. 2012;2:243–248. doi:https://doi.org/10.1007/s12348-012-0074-x.
- Levin MH, Pistilli M, Daniel E, et al. Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema. Ophthalmology. 2014;121(588–95):e1. doi:https://doi.org/10.1016/j.ophtha.2013.09.023.
- Kempen JH, Van Natta ML, Altaweel MM, et al. factors predicting visual acuity outcome in intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment (MUST) trial. Am J Ophthalmol. 2015;160(1133–41):e9. doi:https://doi.org/10.1016/j.ajo.2015.09.017.
- Nazari H, Dustin L, Heussen FM, et al. Morphometric spectral-domain optical coherence tomography features of epiretinal membrane correlate with visual acuity in patients with uveitis. Am J Ophthalmol. 2012;154(78–86):e1. doi:https://doi.org/10.1016/j.ajo.2012.01.032.
- Guex-Crosier Y. The pathogenesis and clinical presentation of macular edema in inflammatory diseases. Doc Ophthalmol. 1999;97:297–309. doi:https://doi.org/10.1023/A:1002130005227.
- van Kooij B, Rothova A, Rijkers GT, de Groot-mijnes JD. Distinct cytokine and chemokine profiles in the aqueous of patients with uveitis and cystoid macular edema. Am J Ophthalmol. 2006;142:192–194. doi:https://doi.org/10.1016/j.ajo.2006.02.052.
- Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987;103:234–235. doi:https://doi.org/10.1016/S0002-9394(14)74235-7.
- Legarreta JE, Gregori G, Knighton RW, et al. Three-dimensional spectral-domain optical coherence tomography images of the retina in the presence of epiretinal membranes. Am J Ophthalmol. 2008;145:1023–1030. doi:https://doi.org/10.1016/j.ajo.2008.01.014.
- Stevenson W, Prospero Ponce CM, Agarwal DR, et al. Epiretinal membrane: optical coherence tomography-based diagnosis and classification. Clin Ophthalmol. 2016;10:527–534. doi:https://doi.org/10.2147/OPTH.
- Ng CH, Cheung N, Wang JJ, et al. Prevalence and risk factors for epiretinal membranes in a multi-ethnic United States population. Ophthalmology. 2011;118:694–699. doi:https://doi.org/10.1016/j.ophtha.2010.08.009.
- Lehpamer B, Moshier E, Pahk P, et al. Epiretinal membranes in uveitic macular edema: effect on vision and response to therapy. Am J Ophthalmol. 2014;157:1048–1055. doi:https://doi.org/10.1016/j.ajo.2014.01.020.
- Munk MR, Bolz M, Huf W, et al. Morphologic and functional evaluations during development, resolution, and relapse of uveitis-associated cystoid macular edema. Retina. 2013;33:1673–1683. doi:https://doi.org/10.1097/IAE.0b013e318285cc52.
- Grajewski RS, Boelke AC, Adler W, et al. Spectral-domain optical coherence tomography findings of the macula in 500 consecutive patients with uveitis. Eye (Lond). 2016;30:1415–1423. doi:https://doi.org/10.1038/eye.2016.133.